The fusion of raw biometric data with algorithmic analysis marks a shift toward proactive telemedicine. Concurrently, Google has launched testing of its advanced medical model `AMIE` for analyzing clinical video consultations. The IT giant is taking control of the most sensitive and high-margin part of human life—health. By processing physiological logs in real time, Google gains the ability not just to provide recommendations, but to construct predictive diagnoses, radically reducing the burden on the classical healthcare system. For the B2C market, this is a new level of trust: users are voluntarily handing algorithms control over their metabolism.
Source: Google / Abbott / AI News
HealthTechGoogleAbbottAMIEB2C